Provided by Tiger Trade Technology Pte. Ltd.

Amgen

413.08
+10.482.60%
Post-market: 412.07-1.0100-0.24%17:34 EDT
Volume:2.24M
Turnover:922.16M
Market Cap:222.44B
PE:25.66
High:415.79
Open:403.06
Low:401.85
Close:402.60
52wk High:447.03
52wk Low:288.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.78
T/O Rate:0.42%
Dividend:9.80
Dividend Rate:2.37%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.03
PE(LYR):29.03

Loading ...

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
1 hour ago

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-07

Reuters
·
2 hours ago

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
5 hours ago

Amgen is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Yesterday

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Yesterday

Movement Alert|Amgen Rises 3.13% in Regular Trading, Dazodalibep Hits Primary Endpoint in Sjogren's Phase 3

Market Focus
·
Yesterday

Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)

TIPRANKS
·
Yesterday

Early notable gainers among liquid option names on October 7th

TIPRANKS
·
Yesterday

Morgan Stanley Adjusts Price Target on Amgen to $359 From $362

MT Newswires Live
·
Yesterday

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Yesterday

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

TIPRANKS
·
Yesterday

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet

Bellwether Stocks Movement
·
Oct 05

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement
·
Oct 05

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement
·
Oct 05

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

Macro World​
·
Oct 03

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement
·
Oct 03

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

TIPRANKS
·
Oct 03

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02